Finalists for CPHI Frankfurt Pharma Awards 2025 showcase innovation in drug development, advanced manufacturing, and future ...

The company, under parent ICE Pharma, will celebrate its past achievements, present its expertise and plans for the future, and unveil a “100 Years” logo.

The company has expanded its CDMO offerings in recent years, adding to decades of experiences in solutions such as moisture management.

Misleading promotions of GLP-1 and compounded semaglutide products are drawing renewed regulatory scrutiny over risk ...

Nevada-based Corstasis Therapeutics (Corstasis) has announced FDA’s approval of its bumetanide nasal spray, Enbumyst, for the ...

Novo Nordisk’s Wegovy will be competing with Madrigal Pharmaceuticals’ Rezdiffra in the metabolic dysfunction-associated ...

UK pharma small- and medium-sized enterprises face funding and R&D barriers. Improved tax relief and targeted incentives are ...

R&D Tax Consultant RCK PartnersUK pharma small- and medium-sized enterprises face funding and R&D barriers. Improved tax relief and targeted incentives are vital to keep UK innovation competitive.

Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...

The two organizations are collaborating on an integrated translational biology platform for the development of ...

Bram Baert, global head of Regulatory Affairs at Lonza CHI, gives his perspective on the impact of the EC’s decision on the ...